JPS57130923A - Remedy and preventive for vertigo - Google Patents
Remedy and preventive for vertigoInfo
- Publication number
- JPS57130923A JPS57130923A JP1734481A JP1734481A JPS57130923A JP S57130923 A JPS57130923 A JP S57130923A JP 1734481 A JP1734481 A JP 1734481A JP 1734481 A JP1734481 A JP 1734481A JP S57130923 A JPS57130923 A JP S57130923A
- Authority
- JP
- Japan
- Prior art keywords
- drug
- vertigo
- remedying
- preventive
- remedy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000012886 Vertigo Diseases 0.000 title abstract 7
- 231100000889 vertigo Toxicity 0.000 title abstract 7
- 230000003449 preventive effect Effects 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 abstract 8
- 239000003814 drug Substances 0.000 abstract 8
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 2
- 230000001387 anti-histamine Effects 0.000 abstract 2
- 239000000739 antihistaminic agent Substances 0.000 abstract 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 2
- 229940125725 tranquilizer Drugs 0.000 abstract 2
- 239000003204 tranquilizing agent Substances 0.000 abstract 2
- 230000002936 tranquilizing effect Effects 0.000 abstract 2
- UOTMYNBWXDUBNX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinolin-2-ium;chloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 UOTMYNBWXDUBNX-UHFFFAOYSA-N 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- YLCXGBZIZBEVPZ-UHFFFAOYSA-N Medazepam Chemical compound C12=CC(Cl)=CC=C2N(C)CCN=C1C1=CC=CC=C1 YLCXGBZIZBEVPZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000002567 autonomic effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 210000001638 cerebellum Anatomy 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 abstract 1
- 229960000729 cyclandelate Drugs 0.000 abstract 1
- -1 diphenhydrynate Chemical compound 0.000 abstract 1
- 229960002819 diprophylline Drugs 0.000 abstract 1
- KSCFJBIXMNOVSH-UHFFFAOYSA-N dyphylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CC(O)CO)C=N2 KSCFJBIXMNOVSH-UHFFFAOYSA-N 0.000 abstract 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 abstract 1
- 229960002225 medazepam Drugs 0.000 abstract 1
- 229960003207 papaverine hydrochloride Drugs 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PURPOSE: The titled theoretical and total remedy and preventive for vertigo, obtained by combining a drug remedying vertigo etiologically with a drug remedying vertigo nosologically.
CONSTITUTION: A drug enhancing the suppressing competence of the cerebelleum of vestibule (e.g., a promotor for cerebral blood stream such as papaverine hydrochloride, cyclandelate, etc., an autonomic suppressant such as γ-orizanol, etc.), or the drug enhancing the suppressing competence of the cerebellum of vestibule and a drug alleviating an increase of susceptibility of an individual (e.g., a tranquilizer such as chloridiazepoxide, medazepam, etc., an antihistamine such as diphenhydrynate, etc.) is used as a drug remedying vertigo etiologically, a drug alleviating caused symptoms or promoting the action[e.g., tranquilizer, antihistamine, caffeine type agent (e.g., diprophylline, etc.)]is used as a drug remedying vertigo nosologically, and they are combined to give a remedy and preventive for vertigo curing it fundamentally.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1734481A JPS57130923A (en) | 1981-02-07 | 1981-02-07 | Remedy and preventive for vertigo |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1734481A JPS57130923A (en) | 1981-02-07 | 1981-02-07 | Remedy and preventive for vertigo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS57130923A true JPS57130923A (en) | 1982-08-13 |
Family
ID=11941430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1734481A Pending JPS57130923A (en) | 1981-02-07 | 1981-02-07 | Remedy and preventive for vertigo |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57130923A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996031222A1 (en) * | 1994-03-23 | 1996-10-10 | Ivan Dimitrov Hristov | Antiasthmatic preparation |
| WO1998050065A3 (en) * | 1997-05-05 | 1999-06-10 | Marion Sangster Eckmiller | The use of biologically active substances for influencing the extracellular area of sensory cells and method for controlling the administration of active substances and device used therein |
| WO2001055083A1 (en) * | 2000-01-27 | 2001-08-02 | Biodep, Inc. | Inositol derivatives and their pharmaceutical use |
| CN107582533A (en) * | 2017-11-09 | 2018-01-16 | 武汉励合生物医药科技有限公司 | A kind of diazepam composition freeze-drying piece and preparation method thereof |
-
1981
- 1981-02-07 JP JP1734481A patent/JPS57130923A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996031222A1 (en) * | 1994-03-23 | 1996-10-10 | Ivan Dimitrov Hristov | Antiasthmatic preparation |
| WO1998050065A3 (en) * | 1997-05-05 | 1999-06-10 | Marion Sangster Eckmiller | The use of biologically active substances for influencing the extracellular area of sensory cells and method for controlling the administration of active substances and device used therein |
| WO2001055083A1 (en) * | 2000-01-27 | 2001-08-02 | Biodep, Inc. | Inositol derivatives and their pharmaceutical use |
| CN107582533A (en) * | 2017-11-09 | 2018-01-16 | 武汉励合生物医药科技有限公司 | A kind of diazepam composition freeze-drying piece and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1201087B (en) | PHARMACOLOGICALLY ACTIVE BIPPHOSPHONES, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS | |
| CZ76995A3 (en) | Derivatives of 1-(oxoacetyl)pipridine-2-carboxylic acid, process of their preparation pharmaceutical composition containing thereof and their use | |
| IT1220979B (en) | CAPSULES CONTAINING AN ALLERGEN AND PROCEDURE FOR THEIR PREPARATION | |
| EP0229444A3 (en) | Medicaments for the treatment of anxiety | |
| IT8619055A0 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES OF THE CHOLECYSTOKININ-CERULIN GROUP FOR THE THERAPEUTIC TREATMENT OF SHOCK STATES AND RESPIRATORY AND CARDIOCIRCULAR INSUFFICIENCY. | |
| DK160129C (en) | PHARMACEUTICAL PREPARATION CONTAINING A GANGLIOSIDE COMPOUND, AN INTERNAL ESTER GANGLIOSIDE DERIVATIVE OR MIXTURES THEREOF | |
| ZA818499B (en) | Agents for combating circulatory illnesses and their use | |
| IT8349450A0 (en) | CERTAIN SUBSTITUTED PYRAZOLE-QUINOLINES, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AND THEIR THERAPEUTIC USE | |
| DK407383A (en) | DIAMINOPYRIMIDINES, PROCEDURES FOR THEIR PREPARATION, THEIR USE AND INTERMEDIATES USED IN THE PREPARATION OF THE COMPOUNDS | |
| JPS57130923A (en) | Remedy and preventive for vertigo | |
| SE8301038L (en) | TIOPYRANOPYRIMIDE COMPOUNDS AND ACID ADDITION SALTS THEREOF | |
| EP0093497A3 (en) | Anthelmintic treatment | |
| NO833529L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALFA-ARYL-ALFA-PYRIDYLALKANIC ACID DERIVATIVES | |
| JPS5793913A (en) | Enhancing agent for spermous vital power | |
| Njaa et al. | Levocabastine compared with sodium cromoglygate eyedrops in children with both birch and grass pollen allergy | |
| IT8349055A0 (en) | B-OXO-L-CARBAMMOYL-PYRROLPROPIONITRILE, PROCEDURE FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS, AS WELL AS THEIR THERAPEUTIC USE | |
| IT1134202B (en) | ADJUVANT TO PROMOTE THE ABSORPTION OF PHARMACOLOGICALLY ACTIVE SUBSTANCES THROUGH THE RECTUM, AND PHARMACEUTICAL COMPOSITION THAT INCLUDE IT | |
| IL48787A0 (en) | Pharmaceutical preparations comprising phentolamine,for the treatment of circulatory disorders | |
| ATE7911T1 (en) | PHARMACEUTICALLY ACCEPTABLE SALTS OF 4'-(9ACRIDINYLAMINO)METHANESULFONE-M-ANISIDE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| JPS5585526A (en) | Remedy for allergic disease | |
| IT8348872A0 (en) | PROCEDURE FOR THE DETERMINATION OF THE STATE OF VIRULENCE OR LATENCE OF THE HERPES VIRUS IN CELLULAR TISSUES | |
| JPS5329916A (en) | Ready absorption oryzanol preparation | |
| IT8222873A0 (en) | STEROID COMPOUNDS WITH CHOLERETIC ACTIVITY, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS WHICH CONTAIN THEM AS THE ACTIVE INGREDIENT. | |
| JPS56110627A (en) | Antiulcer agent | |
| JPS54105237A (en) | Analgesic agent containing nalorphine-6-glucuronide |